
### [NCIT:C3517](http://purl.obolibrary.org/obo/NCIT_C3517)
**Label:** Mixed Cellularity Classical Hodgkin Lymphoma

**Subclasses:** [NCIT:C8063](http://purl.obolibrary.org/obo/NCIT_C8063) (Childhood Mixed Cellularity Classical Hodgkin Lymphoma), [NCIT:C8834](http://purl.obolibrary.org/obo/NCIT_C8834) (Stage I Mixed Cellularity Classical Hodgkin Lymphoma), [NCIT:C8835](http://purl.obolibrary.org/obo/NCIT_C8835) (Stage IV Mixed Cellularity Classical Hodgkin Lymphoma), [NCIT:C8832](http://purl.obolibrary.org/obo/NCIT_C8832) (Recurrent Mixed Cellularity Classical Hodgkin Lymphoma), [NCIT:C8833](http://purl.obolibrary.org/obo/NCIT_C8833) (Refractory Mixed Cellularity Classical Hodgkin Lymphoma), [NCIT:C5077](http://purl.obolibrary.org/obo/NCIT_C5077) (Stage II Mixed Cellularity Classical Hodgkin Lymphoma), [NCIT:C9127](http://purl.obolibrary.org/obo/NCIT_C9127) (Adult Mixed Cellularity Classical Hodgkin Lymphoma), [NCIT:C3582](http://purl.obolibrary.org/obo/NCIT_C3582) (Stage III Mixed Cellularity Classical Hodgkin Lymphoma), 

**Class expressions from DL-Learner:**

- Thing 54.74%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) 36.78%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39873](http://purl.obolibrary.org/obo/NCIT_C39873) (Urethral Glandular Metaplasia))) 36.78%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39872](http://purl.obolibrary.org/obo/NCIT_C39872) (Urethral Villous Adenoma))) 36.78%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39866](http://purl.obolibrary.org/obo/NCIT_C39866) (Female Urethral Malignant Neoplasm))) 36.78%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39864](http://purl.obolibrary.org/obo/NCIT_C39864) (Carcinoma of Cowper Glands))) 36.78%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39862](http://purl.obolibrary.org/obo/NCIT_C39862) (Human Papillomavirus-Related Urethral Squamous Cell Carcinoma))) 36.78%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39859](http://purl.obolibrary.org/obo/NCIT_C39859) (Bladder Inverted Papilloma))) 36.78%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39856](http://purl.obolibrary.org/obo/NCIT_C39856) (Urothelial Dysplasia))) 36.78%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39845](http://purl.obolibrary.org/obo/NCIT_C39845) (Bladder Urachal Squamous Cell Carcinoma))) 36.78%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39844](http://purl.obolibrary.org/obo/NCIT_C39844) (Bladder Urachal Urothelial Carcinoma))) 36.78%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39834](http://purl.obolibrary.org/obo/NCIT_C39834) (Bladder Squamous Papilloma))) 36.78%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39833](http://purl.obolibrary.org/obo/NCIT_C39833) (Schistosoma Hematobium-Related Bladder Verrucous Carcinoma))) 36.78%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39829](http://purl.obolibrary.org/obo/NCIT_C39829) (Infiltrating Bladder Urothelial Carcinoma with Giant Cells))) 36.78%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39826](http://purl.obolibrary.org/obo/NCIT_C39826) (Infiltrating Bladder Urothelial Carcinoma, Sarcomatoid Variant without Heterologous Elements))) 36.78%


